AbCellera Biologics Inc. (ABCL) Stock Price History
Historical prices from 2020 to 2026
Loading 10-year price history...
ABCL Historical Performance
Short-Term Returns
ABCL Stock Price Trajectory (2020–2026)
As of May 8, 2026, AbCellera Biologics Inc. (ABCL) trades at $4.82, representing a +139.8% return over the past year. The stock has delivered a -83.4% total return over five years (-30.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $71.91 on December 11, 2020. From this peak, ABCL has corrected -93.3%, currently trading 16% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers TWST (+78.6% 1Y), RXRX (-22.0% 1Y), and SDGR (-44.0% 1Y), ABCL has outperformed the peer group average. Compare ABCL vs TWST →
ABCL Historical Price Data (2025–2026)
Showing 30 of 1,357 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 5.04 | 5.24 | 4.74 | 4.82 | 11.46M | -4.37% |
| 2026-05-06 | 4.61 | 5.05 | 4.59 | 5.04 | 7.52M | +8.15% |
| 2026-05-05 | 5.04 | 5.16 | 4.57 | 4.66 | 13.25M | +1.53% |
| 2026-05-04 | 4.44 | 4.70 | 4.43 | 4.59 | 7.65M | +3.61% |
| 2026-05-01 | 4.12 | 4.47 | 4.03 | 4.43 | 6.69M | +6.75% |
| 2026-04-30 | 3.88 | 4.16 | 3.83 | 4.15 | 5.94M | +8.64% |
| 2026-04-29 | 4.09 | 4.09 | 3.76 | 3.82 | 12.11M | -8.28% |
| 2026-04-28 | 4.03 | 4.30 | 3.96 | 4.17 | 12.81M | +0.12% |
| 2026-04-27 | 4.13 | 4.38 | 4.11 | 4.16 | 11.88M | 0.00% |
| 2026-04-24 | 4.07 | 4.29 | 3.97 | 4.16 | 9.39M | +2.72% |
| 2026-04-23 | 4.10 | 4.29 | 3.94 | 4.05 | 8.14M | -0.74% |
| 2026-04-22 | 4.05 | 4.21 | 4.00 | 4.08 | 5.29M | +2.26% |
| 2026-04-21 | 3.92 | 3.99 | 3.83 | 3.99 | 3.84M | +2.05% |
| 2026-04-20 | 4.01 | 4.03 | 3.88 | 3.91 | 5.19M | -2.49% |
| 2026-04-17 | 3.92 | 4.05 | 3.87 | 4.01 | 4.76M | +4.70% |
| 2026-04-16 | 3.89 | 3.95 | 3.78 | 3.83 | 2.89M | -0.78% |
| 2026-04-15 | 3.77 | 3.90 | 3.77 | 3.86 | 2.97M | +2.66% |
| 2026-04-14 | 3.78 | 3.83 | 3.69 | 3.76 | 3.14M | +2.73% |
| 2026-04-13 | 3.49 | 3.75 | 3.48 | 3.66 | 2.85M | +3.39% |
| 2026-04-10 | 3.50 | 3.63 | 3.48 | 3.54 | 2.39M | +2.91% |
| 2026-04-09 | 3.37 | 3.45 | 3.37 | 3.44 | 1.96M | +0.29% |
| 2026-04-08 | 3.52 | 3.52 | 3.38 | 3.43 | 2.45M | +3.94% |
| 2026-04-07 | 3.36 | 3.38 | 3.22 | 3.30 | 3.93M | -2.65% |
| 2026-04-06 | 3.54 | 3.58 | 3.39 | 3.39 | 3.18M | -3.69% |
| 2026-04-02 | 3.42 | 3.63 | 3.41 | 3.52 | 3.48M | +0.28% |
| 2026-04-01 | 3.53 | 3.66 | 3.50 | 3.51 | 1.66M | +0.57% |
| 2026-03-31 | 3.35 | 3.57 | 3.35 | 3.49 | 2.96M | +6.40% |
| 2026-03-30 | 3.26 | 3.32 | 3.23 | 3.28 | 2.78M | +0.31% |
| 2026-03-27 | 3.32 | 3.35 | 3.24 | 3.27 | 2.35M | -2.39% |
| 2026-03-26 | 3.33 | 3.52 | 3.31 | 3.35 | 1.75M | -1.18% |
See ABCL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABCL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ABCL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonABCL — Frequently Asked Questions
Quick answers to the most common questions about buying ABCL stock.
How has ABCL stock performed recently?
ABCL returned +139.8% over the past year, beating its 5-year annualized CAGR of -30.2%. The stock trades above its 200-day moving average, confirming the uptrend.
What is ABCL's all-time high price?
AbCellera Biologics Inc. reached $71.91 on 2020-12-11. The 52-week high is $6.52. Current 1-year return of +139.8% places the stock closer to historical peaks.
Where can I download ABCL historical price data?
This page provides ABCL daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.